Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Metastatic Castration-resistant Prostate Cancer
Related studies linked through entity extraction aliases.
Study to Evaluate Exicorilant (CORT125281) in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Onvansertib in Combination With Abiraterone and Prednisone in Adult Patients With Metastatic Castration-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
177Lu-EB-PSMA617 in Patients With Metastatic Castration-resistant Prostate Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Sequencing of Radium-223 and Docetaxel in Symptomatic Bone-only Metastatic Castration-resistant Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Tissue Predictors of Abiraterone Benefit
- Status
- COMPLETED
- Phase
- N/A
A Phase I Study of PCUR-101 in Combination With Androgen Suppression Therapy in the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Autologous Immune Cell Therapy in Combination With LHRH-a in Patients With mCRPC
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of Pembrolizumab (MK-3475) in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)(MK-3475-199/KEYNOTE-199)
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Activity Study of PSCA-Targeted CAR-T Cells (BPX-601) in Subjects With Selected Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study of ZEN003694 in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of ZEN003694 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer Participants Who Responded Poorly to the First-line Combined Androgen Blockade Therapy
- Status
- COMPLETED
- Phase
- PHASE4
Observational Study for the Evaluation of Long-term Safety of Radium-223 Used for the Treatment of Metastatic Castration Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- N/A
Sequencing Abiraterone and Enzalutamide in mCRPC
- Status
- COMPLETED
- Phase
- PHASE2
A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE4
Phase III Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3